28 Nov 2024
MS inclusion in US Pharmacopeia to boost biologics impurity control
By Staff Writer
Mass spectrometry-based analysis of biologics will soon have its own chapter in the US Pharmacopeia. Mass spectrometry (MS) analysis delivers significantly more detailed and informative data than today’s most widely used methods and marks a breakthrough that could revolutionise impurity control in the pharma industry. On 1 December, a new general chapter will be available...
